Title:
DIAGNOSTIC METHODS FOR T CELL THERAPY
Document Type and Number:
Japanese Patent JP2023123716
Kind Code:
A
Abstract:
To provide methods of increasing the efficacy of a T cell therapy in a patient in need thereof.SOLUTION: The invention includes methods of identifying a patient who would respond well to a T cell therapy or conditioning a patient prior to a T cell therapy so that the patient responds well to a T cell therapy. The conditioning involves the steps for administering one or more preconditioning agents prior to a T cell therapy and identifying biomarker cytokines prior to administering a T cell therapy.SELECTED DRAWING: None
Inventors:
ADRIAN BOT
JEFFREY S WIEZOREK
WILLIAM GO
RAJUL JAIN
JAMES N KOCHENDERFER
STEVEN A ROSENBERG
JEFFREY S WIEZOREK
WILLIAM GO
RAJUL JAIN
JAMES N KOCHENDERFER
STEVEN A ROSENBERG
Application Number:
JP2023105613A
Publication Date:
September 05, 2023
Filing Date:
June 28, 2023
Export Citation:
Assignee:
KITE PHARMA INC
US GOVERNMENT
US GOVERNMENT
International Classes:
A61K35/17; A61K31/664; A61K31/7076; A61K45/00; A61P35/00; A61P43/00; C12N15/12; C12N15/13; C12N15/62; G01N33/68
Attorney, Agent or Firm:
Saegusa International Patent Office